Hemangioendothelioma — Trials

Hemangioendothelioma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07684287	A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma	not yet recruiting	Phase 2	40	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY	1	Jul 6, 2026	clinicaltrials
NCT07477548	A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies	not yet recruiting	Phase 2	67	Yonsei UniversityOTHER	0	Mar 17, 2026	clinicaltrials

Data updated 22 days agoSource updated Jul 6, 2026source: clinicaltrials